John Gill - Net Worth and Insider Trading
John Gill Net Worth
The estimated net worth of John Gill is at least $24,579 dollars as of 2024-05-16. John Gill is the Director of Altimmune Inc and owns about 2,771 shares of Altimmune Inc (ALT) stock worth over $24,579. Details can be seen in John Gill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Gill has not made any transactions after 2022-08-12 and currently still holds the listed stock(s).
Transaction Summary of John Gill
John Gill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Gill owns 2 companies in total, including Altimmune Inc (ALT) , and TetraLogic Pharmaceuticals Corp (TLOG) .
Click here to see the complete history of John Gill’s form 4 insider trades.
Insider Ownership Summary of John Gill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALT | Altimmune Inc | 2022-08-12 | director |
| TLOG | TetraLogic Pharmaceuticals Corp | 2013-12-31 | director |
John Gill Latest Holdings Summary
John Gill currently owns a total of 1 stock. John Gill owns 2,771 shares of Altimmune Inc (ALT) as of August 12, 2022, with a value of $24,579.
Latest Holdings of John Gill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALT | Altimmune Inc | 2022-08-12 | 2,771 | 8.87 | 24,579 |
Holding Weightings of John Gill
John Gill Form 4 Trading Tracker
According to the SEC Form 4 filings, John Gill has made a total of 2 transactions in Altimmune Inc (ALT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Altimmune Inc is the sale of 2,714 shares on August 12, 2022, which brought John Gill around $40,710.
Insider Trading History of John Gill
- 1
John Gill Trading Performance
GuruFocus tracks the stock performance after each of John Gill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Gill is -37.94%. GuruFocus also compares John Gill's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Gill within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Gill's insider trading performs compared to the benchmark.
Performance of John Gill
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.06 | | | | | |
| Relative Return to S&P 500(%) | -24.42 | | | | | |
John Gill Ownership Network
John Gill Owned Company Details
What does Altimmune Inc do?
Who are the key executives at Altimmune Inc?
John Gill is the director of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .
Altimmune Inc (ALT) Insider Trades Summary
Over the past 18 months, John Gill made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net purchase of 9,300 shares made by David Drutz , a net sale of 20,000 shares made by Wayne Pisano , and a net purchase of 10,000 shares made by Richard I Eisenstadt .
In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Altimmune Inc (ALT) were sold and 29,300 shares were bought by its insiders, resulting in a net purchase of 9,300 shares.
Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Altimmune Inc Insider Transactions
John Gill Mailing Address
Above is the net worth, insider trading, and ownership report for John Gill. You might contact John Gill via mailing address: C/o Pharmathene, Inc, One Park Place, Suite 450, Annapolis Md 21401.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
